Our Technology

Early Detection Saves Lives

Diving into Our Technology

Our non-intrusive testing, AI-powered cancer detection and patented Cell-CT imaging work together to deliver early detection of lung cancer.

Learn more about our breakthrough technologies below.

Non-Intrusive
Testing

Using Our LuCED® Test Kit

The LuCED test, or Lung Cell Evaluation Device, does not require a blood draw, and uses a non-intrusive sputum sample that will be analyzed to determine your risk of lung cancer.

How We Collect Your Sample

3D Cell Imaging

Using Our Patented Cell-CT
Imaging Platform

Through our AI-powered technology, 3D cell images are able to be pulled and analyzed to determine lung cancer detection. This process is followed up with CellGazer which gives a review of the cell analysis.

How We Test Your Sample

AI-Powered
Cancer Early Detection

Analyzing Results with CellGazer Technology

Through our AI-powered technology, 3D cell images are computed and analyzed to detect abnormal cells in lung cancer. This process is followed up with CellGazer which gives a review of the cell analysis.

How We Analyze Your Sample

VisionGate
Potential

VisionGate’s intellectual property portfolio has comprised over 35 issued patents and 5 patents pending.

For investment opportunities, please contact us to receive our informational memorandum.